Web Analytics

3 Latest Announced Rounds

  • Undisclosed Amount
    Series A

    2 Investors

    Utilities
    Jun 11th, 2025
  • $54,000,000
    Series C
    Software Development
    Jun 11th, 2025
  • $2,852,546
    Pre-Seed
    Technology, Information and Internet
    Jun 11th, 2025
$861.22M Raised in 40 Funding Rounds in the past 7 Days - View All

Funding Round Profile

VerImmune

start up
United States - Washington DC
  • 21/09/2023
  • Unknown
  • $3,000,000

VerImmune is advancing Anti-tumor Immune Redirection (AIR):
A Breakthrough Therapy that Redirects Pre-Existing Immune Memory
from Childhood Vaccination or Infection to Fight Cancer


Related People

Joshua Weiyuan WangFounder

Joshua Weiyuan Wang United States - Washington, District of Columbia

Joshua Wang is a bio-entrepreneur with experience in founding, securing early stage financing and operating early stage biotech companies. His technical background in virology, vaccines and immunology inform his mindful but competitive approach to evolve scientific discoveries into medicines to serve critical unmet needs. Joshua’s experience spans the globe having lived and worked in Singapore, the UK and USA currently.